54741_Image_jpeg.jpg
Daxor Corporation to Present at the 13th Annual LD Micro Main Event 2020
09 déc. 2020 08h30 HE | Daxor Corporation
NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status
03 déc. 2020 11h54 HE | CVRx, Inc.
MINNEAPOLIS, Dec. 03, 2020 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that the Centers for...
CVRx® Announces New CFO and Acceleration of Barostim Therapy Commercialization Efforts
18 nov. 2020 14h56 HE | CVRx, Inc.
MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- CVRx, Inc., developer of FDA-approved Barostim Therapy to treat chronic heart failure (HF), announced a CFO transition as part of the company’s...
logo-brainhq-hi-res-hori.png
Study: Combining Brain Training and Walking Helps Heart Failure Patients
20 oct. 2020 08h00 HE | Posit Science
SAN FRANCISCO, Oct. 20, 2020 (GLOBE NEWSWIRE) -- A new study from Emory University found a combined therapy of brain training and aerobic exercise improved multiple measures that drive better health...
chf.jpg
CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19
07 oct. 2020 08h00 HE | CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
chf.jpg
CHF Solutions Initiatives at HFSA 24th Annual Scientific Meeting Highlight Aquadex Therapy Performance in Heart Failure
30 sept. 2020 08h00 HE | CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Sept. 30, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
chf.jpg
CHF Solutions’ Physician-Led Webinar Concludes Fluid Overloaded Heart Failure Patients Benefit from Ultrafiltration
10 sept. 2020 09h15 HE | CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Sept. 10, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
chf.jpg
CHF Solutions Continues Physician-Led Webinar Series Discussing Precise Management of Fluid Overload in Patients with Acute Heart Failure
03 sept. 2020 08h00 HE | CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Sept. 03, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights
13 août 2020 07h00 HE | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today...
CMHC Concludes CMHC West Live Online: Complexities in Cardiometabolic Care.
11 août 2020 12h00 HE | Cardiometabolic Health Congress
Boca Raton, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- CMHC Concludes CMHC West Live Online: Complexities in Cardiometabolic Care. CMHC West Live Online: Complexities in Cardiometabolic Care concluded...